REGN — REGENERON PHARMACEUTICALS

Ownership history in Quarry LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Quarry LP reported a position in REGENERON PHARMACEUTICALS (REGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.12% (2023 Q1)
Avg. % of fund
0.08%
First filed
2022 Q4
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 657 -17 -2.5% 0.08% $369K $560.89
2023 Q1 ADDED 674 +348 +106.7% 0.12% $554K $816.16
2022 Q4 INITIATED 326 — — 0.05% $235K —
% of Fund (quarterly)    REGN price (monthly, adj. close)

Other funds also holding REGN

As of 2025 Q4 — sorted by position size

Bronte Capital Management Pty Ltd. 3Y 7Y 13.61% Catawba River Capital 3Y 10.08% MCDONALD CAPITAL INVESTORS INC/CA 3Y 7Y 9.86% RK Asset Management, LLC 3Y 7Y 9.22% Orion Investment Co 7.25% SOUTHEASTERN ASSET MANAGEMENT INC/TN/ 3Y 7Y 5.7% GuoLine Advisory Pte Ltd 4.78% Bronte Capital Management Pty Ltd. 3Y 7Y 4.57% Rhenman & Partners Asset Management AB 3Y 7Y 4.43% SOUND SHORE MANAGEMENT INC /CT/ 3Y 7Y 4.32%
← Back to Quarry LP Holdings